Neuronal Connection Between Fat and the Brain Visualized

Researchers pinpoint the neurons within white fat tissue that mediate brain-bound leptin signaling and eventual fat breakdown.

Sep 24, 2015
Anna Azvolinsky

Adipocyte-targeting neurons (red) within adipocytes (green) in the mouse inguinal fat pad.ANA DOMINGOSThe hormone leptin, produced by fat cells, acts as a satiety signal to the brain, resulting in fat breakdown when levels are high. The hormone, present in proportion to the amount of fat tissue, is known to act on hypothalamic neurons in the brain to tell an animal when it’s full and to kick-start the breakdown of fat. Now, a team led by researchers at the Instituto Gulbenkian de Ciencia (IGC) in Portugal and the Rockefeller University in New York City have, for the first time, provided direct visual evidence that some sympathetic neurons from the brain indeed terminate within fat cells. The researchers also used optogenetics to stimulate these neurons within a fat pad in mice and cause the breakdown of fat. Their results were published today (September 24) in Cell.

“This is a very comprehensive study with quite a beautiful dataset,” said Stephanie Fulton, who studies the neural pathways of food-motivated behavior at the University of Montreal in Canada and was not involved in the work. “[The authors] took advantage of powerful techniques to solidify the strong suggestion that white adipose tissue is directly innervated by the central nervous system and clearly demonstrate that leptin activates this sympathetic input.”

“It’s a real tour de force that combines really modern optogenetic and tissue clearing approaches that are being developed to understand the central nervous system [CNS] and are here applied to understand the neural action outside the CNS and in the body,” said Paul Kenny, director of the Experimental Therapeutics Institute at Mount Sinai Hospital in New York who was also not involved in the study.

Previous studies using neuronal tracing methods provided indirect evidence that neurons should be found within white fat tissue because they could not distinguish between neurons that were just passing through the tissue and those that had axon terminals within adipocytes themselves. Nor was there direct evidence for the function of these neurons in fat breakdown.

In the current work, Ana Domingos of the IGC and her colleagues first visualized the 3-D anatomy and structure of a dissected mouse fat pad using an ex vivo optical tomography technique. The fat organ was first made transparent by removal of the fat which leaves behind the extracellular matrix, vasculature, and neural structures. “Adipose tissue is an organ but the only image we have of it is as a blob,” said Domingos. “I wondered what the blob looks like from the inside, if there is there an anatomical complexity that may give us insight into the physiology of the organ.”

The team found axon bundles penetrating the organ. Then, using two-photon microscopy to image deep within the tissue, the researchers were able to visualize neural axons terminating within adipocytes in an intact fat pad in a living mouse. The sympathetic neurons in fat were sparse—the researchers estimated that less than 8 percent of the adipocytes had direct contact with the nerves.

The researchers then used optogenetics to stimulate the sympathetic neurons within a fat pad in mice. They found that these neurons released norepinephrine upon stimulation, as did leptin treatment. Both manipulations resulted in lipolysis—the breakdown of fat tissue. Conversely, genetically ablating the neural connections to the adipose tissue eliminated the effect of leptin. According to Tamas Horvath, a professor of neurobiology at the Yale University School of Medicine who penned an accompanying perspective, this is the first study to apply optogenetic tools to probe the sympathetic nervous system.

While it was known that sympathetic neurons release norepinephrine and that adipocytes have receptors for norepinephrine, the source for the signaling molecule was controversial, as other sources of norepinephrine, such as the adrenal glands, are not required for weight loss, Domingos told The Scientist. “Finding these adipose junctions finally explains how adipose tissue receives its supply of norepineprhine in order to shrink the fat deposits,” said Domingos.

­Next, Domingos would like to find pharmacological ways to specifically activate these adipose-associated neurons, mimicking the effect of leptin as a potential treatment for obesity.

For Kenny, the work is another example of the increasing appreciation for the brain-body connection. “This paper is revealing the broader body and brain connection that we are beginning to better appreciate,” he said.

“Lipolysis is another example of a basic process that occurs outside the brain that can be powerfully influenced by what occurs in the brain,” Kenny added. “The brain doesn’t function in isolation but communicates with other organs in beautiful ways.”

W. Zeng et al., “Sympathetic neuro-adipose connections mediate leptin-driven lipolysis,” Cell, doi:10.1016/j.cell.2015.08.055, 2015.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!